Syndromic testing – the future of molecular diagnostics
Syndromic testing with the QIAstat-Dx system allows you to rapidly and simultaneously survey a large number of pathogens in a single sample. This means you can get comprehensive diagnostic answers in around an hour. And patients can get the right treatment faster.
To learn more about the benefits of QIAstat-Dx syndromic testing and hear about the latest insights on molecular diagnostics for infectious disease, watch our most recent webinars.
Watch the webinars
Bring the accuracy of syndromic testing to your lab
Make the right choice for your lab – contact us today.
QIAstat-Dx resources and further reading
The QIAstat-Dx Analyzer and QIAstat-Dx Respiratory SARS-CoV-2 Panel are intended for in vitro diagnostic use.
Product availability and claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.